Share this Job

Molecular Pharmacology Scientist

 
Requistion ID:  450
Location: 

Copenhagen, N/A, DK

Date:  08-Jul-2019
 

Molecular Pharmacology Scientist – Department for Molecular Screening and Pharmacology

 

Description

We are looking for a highly motivated scientist to join the Section for Receptors & Enzymes in the Department for Molecular Screening & Pharmacology. The Department is responsible for supporting Lundbeck’s drug discovery projects using state of art assay platforms. The techniques represented in the Department include various in vitro enzyme activity and radioligand binding assays, cell-based assays (GPCRs and ion channels) using both end-point and kinetic readouts, and a range of tip-based or acoustic liquid handlers. The Department currently consists of 9 academics and 4 technicians and is based at Lundbeck’s headquarters in Valby, Copenhagen.

 

Your job and key responsibilities

You will be part of a team providing molecular pharmacology and screening support for research projects aiming at identifying new drug candidates for psychiatric and neurological diseases. You will be responsible for planning and executing laboratory studies and you should expect that app 80% of your work will be lab-based generating and analyzing pharmacology data to support assay development, screening, and hit validation. The aim is to understand the structure-activity relationship and mechanism of action at the molecular target for new drug candidates. Much of the lab work will be based on advanced instrumentation and robotics for automation. You will work closely together with technicians and academics in the department and be involved in cross-functional project teams and CRO interactions.

 

We offer

The opportunity to join a team of highly qualified colleagues working in an open atmosphere with excellent development possibilities. Lundbeck is a global pharmaceutical company with approximately 5,000 employees in 55 countries specialized in psychiatric and neurological disorders.

 

Qualifications

Our preferred candidate has the following personal and professional qualifications:

  • Master and PhD degree in molecular pharmacology, biochemistry, molecular cell biology or related areas.
  • Excellent receptor pharmacology understanding and high scientific standards.
  • In depth knowledge and experience working with GPCRs.
  • Experience with drug discovery and BRET assays is an advantage.
  • Genuine interest in laboratory work.
  • Flair for handling advanced instrumentation and robotics required.
  • Efficient and goal oriented work style with flexible mind-set.
  • Team player with strong collaboration and communication skills.
  • Fluent in oral and written English.

 

Further information

Please contact Senior Director and Head of Department, Molecular Screening and Pharmacology, Lena Tagmose LETA@lundbeck.com or Principal Scientist, Søren Møller Nielsen SMN@lundbeck.com. Your application and CV should not be sent via email but using the link below. We also recommend that you have a look at our website.

 

Your application

Please click on the link below to apply for the job. Applications must be received no later than August 19th, 2019. We will be conducting interviews as we receive applications.

 

 

 

 

 

Lundbeck is a global pharmaceutical company specialized in brain diseases. For more than 70 years, we have been at the forefront of neuroscience research. We are tirelessly dedicated to restoring brain health, so every person can be their best.


An estimated 700 million people worldwide are living with brain diseases and far too many suffer due to inadequate treatment, discrimination, a reduced number of working days, early retirement and other unnecessary consequences. Every day, we strive for improved treatment and a better life for people living with brain diseases – we call this Progress in Mind.

Read more at www.lundbeck.com/global/about-us/progress-in-mind.
Our approximately 5,000 employees in more than 50 countries are engaged in the entire value chain throughout research, development, production, marketing and sales. Our pipeline consists of several late-stage development programs and our products are available in more than 100 countries. Our research center is based in Denmark and our production facilities are located in Denmark, France and Italy. Lundbeck generated revenue of DKK 18.1 billion in 2018 (EUR 2.4 billion; USD 2.8 billion).

For additional information, we encourage you to visit our corporate site www.lundbeck.com and connect with us on Twitter at @Lundbeck and via LinkedIn.